Cell line name |
WIF-B9 |
Synonyms |
WI-38/Fao hybrid-B9 |
Accession |
CVCL_A5BJ |
Resource Identification Initiative |
To cite this cell line use: WIF-B9 (RRID:CVCL_A5BJ) |
Comments |
Doubling time: 2.6 +- 0.1 days (PubMed=17276572). |
Species of origin |
Homo sapiens (Human) (NCBI Taxonomy: 9606)
Rattus norvegicus (Rat)
(NCBI Taxonomy: 10116) |
Hierarchy |
Parent: CVCL_A050 (WIF-B) Children:
|
Category |
Hybrid cell line |
Publications | PubMed=9462660; DOI=10.1002/hep.510270236 Bravo P., Bender V., Cassio D. Efficient in vitro vectorial transport of a fluorescent conjugated bile acid analogue by polarized hepatic hybrid WIF-B and WIF-B9 cells. Hepatology 27:576-583(1998) PubMed=9657109; DOI=10.1002/hep.510280122 Chaumontet C., Mazzoleni G., Decaens C., Bex V., Cassio D., Martel P. The polarized hepatic human/rat hybrid WIF 12-1 and WIF-B cells communicate efficiently in vitro via connexin 32-constituted gap junctions. Hepatology 28:164-172(1998) PubMed=12606785; DOI=10.1124/mol.63.3.742 Briz O., Macias R.I.R., Vallejo M., Silva A., Serrano M.A., Marin J.J.G. Usefulness of liposomes loaded with cytostatic bile acid derivatives to circumvent chemotherapy resistance of enterohepatic tumors. Mol. Pharmacol. 63:742-750(2003) PubMed=17276572; DOI=10.1016/j.tox.2006.12.022 Briz O., Cassio D., Blazquez A.G., Grosse B., Serrano M.A., Marin J.J.G. Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification. Toxicology 232:24-36(2007) |
Cross-references |
Anatomy/cell type resources |
BTO; BTO:0006309
|
Encyclopedic resources |
Wikidata; Q107117446
|
Entry history |
Entry creation | 20-May-2021 |
Last entry update | 21-Mar-2023 |
Version number | 3 |
---|